Due to improved inventory and projected supply, the Centers for Disease Control and Prevention (CDC) has expanded the Advisory Committee on Immunization Practices' (ACIP) recommendations for routine vaccination of adolescents with the quadrivalent meningococcal conjugate vaccine.1,2
The CDC's Advisory Committee on Immunization Practices NOW recommends:1
- Routine meningococcal vaccination for all adolescents 11 through 18 years of age1
- The pre-adolescent visit at 11- 12 years of age is the best time to vaccinate1
- Previously unvaccinated 11- to 18-year olds should be immunized at the earliest possible health-care visit
MMWR Original
Recommendations
Click on image to view and download
MMWR Expanded
Recommendations
Click on image to view and download
The CDC also encourages health-care professionals to continue to call back those adolescent patients who had their meningococcal vaccination deferred.3
References:
1. The Immunization Action Coalition New Releases: Licensures, Recommendations and Resources page. ACIP Meeting Summary, June 27-28, 2007. Available at: http://www.immunize.org/acip/ACIP_meeting_summary607.pdf. Accessed August 2, 2007.
2. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease and Meningococcal disease and college students: recommendations of the Advisory Committee of Immunization Practices (ACIP). MMWR. 2005;54(RR-7):1-21.
3. CDC. Notice to readers: improved supply of meningococcal conjugate vaccine, recommendation to resume vaccination of children aged 11–12 years. MMWR. 2006;55(43):1177.